---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-036829"
form_type: "8-K"
ticker: "AGEN"
cik: "0001098972"
company_name: "AGENUS INC"
filed_at: "2025-03-11T23:59:59+00:00"
generated_at: "2026-05-24T23:11:29.492821+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Agenus Q4 net loss $46.8M; targets annual cash burn of ~$50M by mid-2025

## Summary
- Q4 2024 net loss $46.8M ($2.04/share); full-year net loss $232.3M ($10.59/share).
- Revenue Q4 $26.8M, full-year $103.5M (largely non-cash royalty).
- Cash balance $40.4M at Dec 31, 2024, down from $76.1M year-end 2023.
- Operational cash burn $28.7M in Q4; plan to cut annualized burn to ~$50M by mid-2025.
- BOT/BAL program shows durable responses in colorectal cancer; partnership discussions ongoing.

## SEC filing metadata
- accession: 0000950170-25-036829
- form_type: 8-K
- ticker: AGEN
- cik: 0001098972
- company_name: AGENUS INC
- filed_at: 2025-03-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1098972/000095017025036829/0000950170-25-036829-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1098972/000095017025036829/agen-20250311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-036829
- JSON: https://secwatch.observer/filing/0000950170-25-036829.json
- Plain text: https://secwatch.observer/filing/0000950170-25-036829.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.